Claudia Maria Hammes

Title: Claudia Maria Hammes: Innovator in Transmucosal Delivery of Antidiabetic Peptides

Introduction

Claudia Maria Hammes is a notable inventor based in Andernach, Germany. She has made significant contributions to the field of pharmaceutical delivery systems, particularly focusing on the transmucosal delivery of antidiabetic peptides. Her innovative work aims to improve the treatment options available for diabetes mellitus.

Latest Patents

Claudia holds a patent for a film-like form of administration for the transmucosal delivery of antidiabetic peptides. This invention relates to methods that facilitate the delivery of active compounds such as insulins, insulin analogs, incretins, and incretin mimetics through the oral mucosa. The patent represents a significant advancement in the way diabetes treatments can be administered, potentially enhancing patient compliance and effectiveness.

Career Highlights

Claudia is associated with LTS Lohmann Therapie-Systeme AG, where she continues to develop innovative solutions in drug delivery. Her work is characterized by a commitment to improving patient outcomes through scientific research and development.

Collaborations

Claudia has collaborated with notable colleagues, including Markus Müller and Christoph Schmitz. These partnerships have contributed to her success in the field and have fostered a collaborative environment for innovation.

Conclusion

Claudia Maria Hammes is a pioneering inventor whose work in the transmucosal delivery of antidiabetic peptides is making a significant impact in diabetes treatment. Her contributions highlight the importance of innovation in healthcare and the potential for improved patient care through advanced drug delivery systems.